OCTAGAM normal immunoglobulin (human) 2.5g/50mL injection bottle Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

octagam normal immunoglobulin (human) 2.5g/50ml injection bottle

octapharma australia pty ltd - human immunoglobulin g, quantity: 50 mg/ml - injection - excipient ingredients: water for injections; octoxinol 10; human immunoglobulin a; tributyl phosphate; maltose - replacement therapy: primary immunodeficiency syndromes: congenital agammaglobulinaemia and hypogammaglobulinaemia; common variable immunodeficiency; severe combined immunodeficiencies; wiskott aldrich syndrome; myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections. children with congenital acquired immune deficiency syndrome (aids) who have repeated bacterial infections; immunomodulatory effect: idiopathic thrombocytopenic purpura, in adults or children with a high risk of bleeding or prior to surgery to correct platelet count. guillain barre syndrome. kawasaki disease. allogeneic bone marrow transplantation.

OCTAGAM normal immunoglobulin (human) 1g/20mL injection vial Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

octagam normal immunoglobulin (human) 1g/20ml injection vial

octapharma australia pty ltd - human immunoglobulin g, quantity: 50 mg/ml - injection - excipient ingredients: human immunoglobulin a; octoxinol 10; tributyl phosphate; maltose; water for injections - replacement therapy: primary immunodeficiency syndromes: congenital agammaglobulinaemia and hypogammaglobulinaemia; common variable immunodeficiency; severe combined immunodeficiencies; wiskott aldrich syndrome; myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections. children with congenital acquired immune deficiency syndrome (aids) who have repeated bacterial infections; immunomodulatory effect: idiopathic thrombocytopenic purpura, in adults or children with a high risk of bleeding or prior to surgery to correct platelet count. guillain barre syndrome. kawasaki disease. allogeneic bone marrow transplantation.

ALBUMIN HUMAN 20 % OCTAPHARMA SOLUTION Južná Afrika - angličtina - South African Health Products Regulatory Authority (SAHPRA)

albumin human 20 % octapharma solution

octapharma south africa (pty) ltd - solution - see ingredients - each 1000,0 ml solution contains albumin 200,0 g

Transfer set, fluid Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

transfer set, fluid

octapharma australia pty ltd - 16610 - transfer set, fluid - a collection of items used to transfer medicines from one container to another, and then to filter the fluid medication. this is a single-use device.

Octalbin Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

octalbin

octapharma new zealand ltd - albumin 50 g/l;   - solution for infusion - 5 % - active: albumin 50 g/l   excipient: n-acetyl-dl-tryptophan octanoic acid potassium sodium water for injection - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendations.

Medicine administration kit, percutaneous, non-medicated, single-use Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

medicine administration kit, percutaneous, non-medicated, single-use

octapharma australia pty ltd - 45158 - medicine administration kit, percutaneous, non-medicated, single-use - a collection of devices used to transfer medicines from one container to another, then to filter the fluid medication and finally for transient intravenous administration of the medicine.

Nuwiq Európska únia - angličtina - EMA (European Medicines Agency)

nuwiq

octapharma ab - simoctocog alfa - hemophilia a - blood coagulation factors - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).nuwiq can be used for all age groups.